Search results
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Uveitis History Linked to Recurrence After COVID Vaccination
MedPage Today· 4 days ago(HR 2.07, 95% CI 1.40-3.07). "These findings suggest that there was an elevated risk of uveitis...
Pfizer's Options: A Look at What the Big Money is Thinking - Pfizer (NYSE:PFE)
Benzinga· 3 days agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal ...
Covid-19 Vaccination Associated With Reductions In Pediatric Cases And Hospitalizations
Forbes· 4 days agoA California-based study found that thanks to the state’s Covid-19 immunization program, there was a...
Pfizer collab with Austrian research institute leads to new AI models for drug discovery
FierceBiotech· 3 days agoA three-year collaboration between Pfizer and the Research Center for Molecular Medicine of the...
Pfizer Options Trading: A Deep Dive into Market Sentiment - Pfizer (NYSE:PFE)
Benzinga· 7 days agoWhile it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal ...
University of South Carolina professor became an anti-vax star. He says he didn't mean to.
The Post and Courier· 19 hours agoSince Buckhaults’ testimony, strong criticism has emerged to his interpretation of his results....
Earnings playbook: Your guide to the busiest week of the season, including Apple and Amazon
CNBC· 18 hours agoIt's the busiest week of the earnings season, and it could have major consequences for the stock...
X’s Community Notes Accurately Corrected Vaccine Misinformation 97% Of The Time Last Year, Study...
Forbes· 5 days agoThe relatively new community notes feature on X, formerly known as Twitter, almost always featured...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 4 days agoAfter hitting a two-year high in February, biotech stocks have pulled back markedly in April. In...